Chemotherapy in patients with desmoid tumors: A study from the French Sarcoma Group (FSG)

Annals of Oncology

Volumn 23, Issue 1, 2012, Pages 182-186

  Garbay, D ^a   Le Cesne, A ^b   Penel, N ^c   Chevreau, C ^d   Marec Berard, P ^e   Blay, J Y ^f   Debled, M ^a   Isambert, N ^g   Thyss, A ^h   Bompas, E ⁱ   Collard, O ^j   Salas, S ^k   Coindre, J M ^a   Bui, B ^a   Italiano, A ^a  

^a INSTITUT BERGONIÉ   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d INSTITUT CLAUDIUS REGAUD   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f CENTRE LÉON BÉRARD   (France)

^g CENTRE GEORGES FRANÇOIS LECLERC   (France)

^h CENTRE ANTOINE LACASSAGNE   (France)

ⁱ CENTRE RENÉ GAUDUCHEAU   (France)

^j Institut de Cancerologie de la Loire   (France)

^k TIMONE HOSPITAL   (France)

more..

Author keywords

Aggressive fibromatosis; Chemotherapy; Desmoid tumor

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMATINIB; MESNA; METHOTREXATE; NAVELBINE; NONSTEROID ANTIINFLAMMATORY AGENT; VINBLASTINE;

ADOLESCENT; ADULT; AGED; ARM; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER STAGING; CHILD; CONTROLLED STUDY; DESMOID TUMOR; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; FRANCE; GARDNER SYNDROME; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FIBROMATOSIS, AGGRESSIVE; FRANCE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METHOTREXATE; MIDDLE AGED; VINBLASTINE; YOUNG ADULT;

EID: 84855169442     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr051     Document Type: Article

References (25)

1. Fiore M, Rimareix F, Mariani L et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol 2009; 16(9): 2587-2593.
2. Hansmann A, Adolph C, Vogel T et al. High-dose tamoxifen and sulindac as firstline treatment for desmoid tumors. Cancer 2004; 100: 612-620.
3. Mace J, Sybil Biermann J, Sondak V et al. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer 2002; 95(11): 2373-2379.
4. Penel N, Le Cesne A, Bui BN et al. Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol 2011; 22: 452-457.
5. Gounder MM, Antonescu C, Hameed MR et al. Activity of sorafenib against desmoid tumor/deep fibromatosis (DT/DF). J Clin Oncol 2010; 28 (Suppl): 15S Abstr 10013.
6. Weiss AJ, Lackman RD. Low-dose chemotherapy of desmoid tumors. Cancer 1989; 64(6): 1192-1194.
7. Seiter K, Kemeny D. Successful treatment of a desmoid tumor with doxorubicin. Cancer 1993; 71: 2242-2244.
8. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer 1993; 72: 3244-3247.
9. Skapek SX, Hawk BJ, Hoffer FA et al. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol 1998; 16: 3021-3027.
10. Reich S, Overberg-Schmidt US, Bührer C et al. Low-dose chemotherapy with vinblastine and methotrexate in chidhood desmoid tumors. J Clin Oncol 1999; 17(3): 1086.
11. Azzarelli A, Gronchi A, Bertulli R et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced agressive fibromatosis. Cancer 2001; 92: 1259-1264.
12. Gega M, Yanagi H, Yoshikawa R et al. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol 2006; 24(1): 102-105.
13. Skapek SX, Ferguson WS, Granowetter L et al. Vinblastine and methotrexate for desmoids fibromatosis in children: results of a pediatric oncology group phase II trial. J Clin Oncol 2007; 25: 501-506.
14. Bertagnolli MM, Morgan JA, Fletcher CD et al. Multimodality treatment of mesenteric desmoids tumors. Eur J Cancer 2008; 44(16): 2404-2410.
15. Ezumi K, Yamamoto H, Takesama I et al. Dacarbazine-Doxorubicin ameliorated an extremely aggressive mesenteric desmoids tumor associated with familial adenomatous polyposis: report of a case. Jpn J Clin Oncol 2008; 38(3): 222-226.
16. Constantinidou A, Jones RL, Scurr M et al. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer 2009; 45: 2930-2934.
17. Weiss AJ, Horowitz S, Lackman RD et al. Therapy of desmoid tumors and fibromatosis using vinorelbine. Am J Clin Oncol 1999; 22: 193-195.
18. Okuno SH, Edmonson JH. Combination chemotherapy for desmoids tumors. Cancer 2003; 97: 1134-1135.
19. Meazza C, Bisogno G, Gronchi A et al. Aggressive fibromatosis in children and adolescents. The Italian experience. Cancer 2010; 116: 233-240.
20. De Camargo VP, Keohan ML, D'Adamo DR et al. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer 2010; 116: 2258-2265.
21. Constantinidou A, Jones RL, Scurr M et al. Advanced aggressive fibromatosis: effective palliation with chemotherapy. Acta Oncol 2010 Aug 30; [Epub ahead of print].
22. Fletcher C, Unni K, Mertens F. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press 2002.
23. Eisenhauer EA, Therasse P Bogaerts J et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
24. Ballo MT, Zagars GK, Pollack A et al. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999; 17: 158-167.
25. Lazar AJ, Tuvin D, Hajibashi S et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 2008; 173(5): 1518-1527.